A landmark study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology company integrating optogenetics, ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Yet, even as we celebrate these strengths, it is clear that the next phase of growth will not be driven by volume alone. To remain globally competitive and meet the complex health needs of the future, ...

Viruses and bacteria are always trying to sneak into our bodies, but researchers at the University of Missouri are ...

JHU's Neurofibromatosis Therapeutic Acceleration Program celebrated the 10th anniversary of its Francis S. Collins Scholars ...

There are all these drugs available, sitting in your local pharmacy, but they aren’t being used to treat all the conditions ...

UC Santa Barbara researchers and collaborators from campus biotech spinoff Integrated Biosciences, as well as Harvard, MIT ...

Integrated Biosciences, a biotechnology company integrating optogenetics, chemistry and AI to discover small molecule therapeutics for age-related diseases, today announced the publication of a ...

The three philanthropists devoted themselves and their resources to important causes during lifetimes of service to Palm Beach and beyond.

Learn more about the research of Mayo Clinic's Gene Editing and Cellular Engineering Laboratory led by David (Chun-Wei) D.

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

A major scientific advance in protein modeling developed by Microsoft Research AI for Science, has been published in Science.